【摘要】 目的:评价阿奇霉素序贯治疗儿童社区获得性肺炎(CAP)的疗效及成本。方法:将118例CAP患儿随机分为阿奇霉素序贯治疗组(A组)和头胞他啶静脉注射治疗组(B组),观察临床治疗效果并作最小成本分析。结果:A组与B组总成本分别为(612±7．3)元、(819±8．2)元(P<0．05),疗效为91．94％,82．14％(P>0．05)。结论:阿奇霉素序贯治疗是治疗儿童CAP的较佳方案。更多还原

【Abstract】 Objective:To:investigate the curative effects and cost of sequential treatment of children communityacquired pneumoni(CAP) with azithromycin. Method:118 cases of CAP from this hospital were divided into two groups: sequential azithromycin therapeutic group (Group A) and iv ceftazidime group (Group B). Their clinical effect was observed and cost minimization analysis was carried out. Result:The total costs were 612±7. 3 yuan and 819±8. 2 yuan(P <0.05) and the effective rates were 91.94% and 82.14% (P>0.05) in Group A and Group B respectively. Conclusion: The sequential azithromycin scheme is a better one to treat CAP.更多还原